A multicenter analysis of individuals with a 47,XXY/46,XX karyotype
Tiffany Guess, Ferrin C. Wheeler, Ashwini Yenamandra, Samantha L.P. Schilit, Hannah S. Anderson, Kat...
With over twenty years of invaluable experience and more than 400 completed studies in Phase I-IV clinical trials, we pride ourselves on our unparalleled expertise and knowledge in the field. We are committed to taking a unique and sophisticated approach to understanding disease mechanisms and effectively translating this into the unique requirements of each clinical trial.
MPLN has been at the forefront of speciality reference laboratory services for over thirty-five years, excelling in pathology, hematopathology, molecular diagnostics, infectious disease testing, and women’s health. Our accredited reference laboratory, recognized by the College of American Pathologists (CAP), ISO 15189, and the New York State Department of Health (NYSDOH), is dedicated to delivering actionable, personalized results for better patient outcomes.
OUR FOCUS is bringing innovative technology to patient care. Molecular Pathology Laboratory Network (MPLN) is a leader in laboratory medicine, hematopathology, solid tumor oncology, immunology, and women’s health. Since our inception in 1989, we have pioneered the application of molecular pathology techniques in diagnostic and clinical research applications.
OUR APPROACH offers a unique understanding of the disease mechanism, integrating data from anatomic, cellular, and molecular investigations to provide physicians and clinical research teams with actionable information for patient monitoring and treatment decisions.
OUR COMMITMENT is that our CAP/CLIA & ISO 15189 accredited Global Laboratory Network will deliver high-quality data, maintain exceptional customer service, and provide project management and data management services, making us the ideal partner to support clinical patient management and advance your new therapeutic and IVD/CDx medical device projects.
Tiffany Guess, Ferrin C. Wheeler, Ashwini Yenamandra, Samantha L.P. Schilit, Hannah S. Anderson, Kat...
The realm of clinical trials is continuously evolving, with digital pathology emerging as a transfor...
Pillar Biosciences, Inc., the leader in Decision Medicine™, has announced that Molecular Pathology L...
Unusual Acute Promyelocytic Leukemia, reflexed for FISH analysis; t(15;17) positive.
Our LIS Blue is a fast, easy-to-use, secure, and accessible laboratory information system developed using the latest web technology.
Providing an expanding menu of molecular diagnostics, specialty anatomic pathology, flow cytometry, fluorescence in situ hybridization, and cytogenetic testing, MPLN is dedicated to providing superior diagnostic services to our clients in biopharma, pathology groups, hospitals, medical laboratories, and physician groups nationwide. With a patient-focused approach, we honor an obligation to provide:
Contact our client services team today.